| 0 (0%) | 12-27 00:24 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.33 | 1-year : | 0.54 |
| Resists | First : | 0.28 | Second : | 0.46 |
| Pivot price | 0.01  |
|||
| Supports | First : | 0 | Second : | 0 |
| MAs | MA(5) : | 0 |
MA(20) : | 0.04 |
| MA(100) : | 0.16 |
MA(250) : | 0.88 |
|
| MACD | MACD : | -0.1  |
Signal : | -0.1 |
| %K %D | K(14,3) : | 7.2 |
D(3) : | 5.5 |
| RSI | RSI(14): 37.6 |
|||
| 52-week | High : | 3.13 | Low : | 0 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PLXP ] has closed above bottom band by 17.7%. Bollinger Bands are 83.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.01 - 0.01 | 0.01 - 0.01 |
| Low: | 0.01 - 0.01 | 0.01 - 0.01 |
| Close: | 0.01 - 0.01 | 0.01 - 0.01 |
Wed, 12 Apr 2023
Why Is PLx Pharma (PLXP) Stock Down 32% Today? - InvestorPlace
Thu, 10 Nov 2022
Pre-Market Earnings Report for November 11, 2022 : AQN, ERJ, ORLA, DDL, RGF, IMV, CMMB, PLXP, STRR, CRKN - Nasdaq
Mon, 15 Aug 2022
PLx Pharma Looks At Alternatives As Vazalore Faces Macro Headwinds - Yahoo Finance
Tue, 26 Jul 2022
PLx Pharma (NASDAQ:PLXP) shareholders have endured a 89% loss from investing in the stock a year ago - Yahoo Finance
Mon, 20 Sep 2021
A New Aspirin From PLX Has Investors’ Hearts Pounding - Barron's
Fri, 07 Jul 2017
Money Makers: Houston pharma co., construction company file multimillion-dollar raises - The Business Journals
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 29 (M) |
| Held by Insiders | 2.525e+007 (%) |
| Held by Institutions | 15.3 (%) |
| Shares Short | 142 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -6.431e+007 |
| EPS Est Next Qtrly | -0.47 |
| EPS Est This Year | -1.62 |
| EPS Est Next Year | -1.83 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 417.7 % |
| Return on Equity (ttm) | -64.4 % |
| Qtrly Rev. Growth | 4.54e+006 % |
| Gross Profit (p.s.) | -24.04 |
| Sales Per Share | -19.18 |
| EBITDA (p.s.) | 867347 |
| Qtrly Earnings Growth | -0.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -59 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 0.06 |
| Dividend | 0 |
| Forward Dividend | 246170 |
| Dividend Yield | 0% |
| Dividend Pay Date | 2017-04-19 |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|